Inflacam

RSS

meloxicam

Authorised
This medicine is authorised for use in the European Union.

Overview

Inflacam is an anti-inflammatory medicine used in cattle, pigs, horses, dogs and cats.

Inflacam contains the active substance meloxicam and is a generic medicine. This means that Inflacam contains the same active substance and works in the same way as a ‘reference medicine’ already authorised in the European Union (EU) called Metacam.

Cattle
In cattle, Inflacam is used together with appropriate antibiotic therapy, to reduce clinical signs of acute respiratory infection (infection of the lungs and airways). It can be used with oral re-hydration therapy (medicines given by mouth to restore water levels in the body) to reduce diarrhoea in calves of over one week of age and young, non-lactating cattle. It can also be used as supportive therapy in the treatment of acute mastitis (inflammation of the udder), in combination with antibiotics.

Pigs
In pigs, Inflacam is used to reduce lameness and inflammation in non-infectious locomotor disorders (diseases that affect the ability to move), for the relief of post-operative pain after minor soft tissue surgery such as castration, and for supportive therapy together with appropriate antibiotic therapy in the treatment of diseases that occur after farrowing (giving birth) such as puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome). Septicaemia and toxaemia are conditions where bacteria circulate in the blood and produce harmful substances (toxins).

Horses
In horses, Inflacam is used to reduce pain associated with colic (abdominal pain) and to lessen inflammation and relieve pain in acute and chronic musculo-skeletal disorders (disorders affecting the muscles and bones).

Dogs
In dogs, Inflacam is used to reduce post-operative pain and inflammation following orthopaedic (e.g. fracture operation) and soft tissue surgery. Moreover, it is used to lessen inflammation and pain in acute and chronic musculo-skeletal disorders.

Cats
In cats, Inflacam is used to reduce post-operative pain and inflammation after ovariohysterectomy (spaying operation), orthopaedic and minor soft tissue surgery. Moreover it is used to lessen inflammation and pain in acute and chronic musculo-skeletal disorders in cats.

This EPAR was last updated on 27/03/2019

Authorisation details

Product details
Name
Inflacam
Agency product number
EMEA/V/C/002497
Active substance
meloxicam
International non-proprietary name (INN) or common name
meloxicam
Species
  • Horses
  • Dogs
  • Cats
  • Cattle
  • Pigs
Anatomical therapeutic chemical veterinary (ATCvet) codes
QM01AC06
GenericGeneric

This is a generic medicine, which is developed to be the same as a medicine that has already been authorised, called the reference medicine. A generic medicine contains the same active substance(s) as the reference medicine, and is used at the same dose(s) to treat the same disease(s). For more information, see Generic and hybrid medicines.

Publication details
Marketing-authorisation holder
Chanelle Pharmaceuticals Manufacturing Ltd
Revision
9
Date of issue of marketing authorisation valid throughout the European Union
09/12/2011
Contact address

Dublin Road
Loughrea
Co. Galway
Ireland

Product information

20/06/2019 Inflacam - EMEA/V/C/002497 - WS/1618

Contents

Please note that the size of the above document can exceed 50 pages.

You are therefore advised to be selective about which sections or pages you wish to print.

Pharmacotherapeutic group

  • Anti inflammatory and antirheumatic products
  • non steroids

Therapeutic indication

Dogs: alleviation of inflammation and pain in both acute and chronic musculo-skeletal disorders.

To reduce post-operative pain and inflammation following orthopaedic and soft tissue surgery.

Cats: to reduce post-operative pain after ovariohysterectomy and minor soft tissue surgery.

Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.

Alleviation of pain and inflammation in acute and chronic musculo-skeletal disorders in cats.

Cattle: for use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs.

For use in diarrhoea in combination with oral re‑hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.

For adjunctive therapy in the treatment of acute mastitis, in combination with antibiotic therapy.

For the relief of post-operative pain following dehorning in calves.

Pigs: for use in non-infectious locomotor disorders to reduce the symptoms of lameness and inflammation.

For adjunctive therapy in the treatment of puerperal septicaemia and toxaemia (mastitis-metritis-agalactia syndrome) with appropriate antibiotic therapy.

For the relief of post operative pain associated with minor soft tissue such as castration.

Horses: alleviation of inflammation and relief of pain in both acute and chronic musculo-skeletal disorders.

For the relief of pain associated with equine colic.

Assessment history

Changes since initial authorisation of medicine

How useful was this page?

Add your rating